Life Science Investing NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
Life Science Investing NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
Life Science Investing NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
